Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hohenberger

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 14, 2003
[Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]C Stroszczynski, G Gaffke, S Gretschel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiativeB Kasper, C Baumgarten, S Bonvalot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2010
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group studyJ R Kroep, M Ouali, H Gelderblom, et al.
British Journal of Cancer|June 24, 2010
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experienceP Ströbel, R Bargou, A Wolff, et al.
British Journal of Cancer|June 18, 2014
Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasisA Schmaus, S Klusmeier, M Rothley, et al.
British Journal of Cancer|July 19, 2012
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG studyS Sleijfer, T Gorlia, C Lamers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)B Kasper, C Baumgarten, J Garcia, et al.
Annals of Surgery|April 4, 1998
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trialB Rau, P Wust, P Hohenberger, et al.
British Journal of Cancer|April 21, 2011
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) studyN Penel, M V Glabbeke, S Mathoulin-Pelissier, et al.
ESMO Open|July 16, 2021
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)M Eriksson, P Reichardt, H Joensuu, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 14, 2003
[Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]C Stroszczynski, G Gaffke, S Gretschel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiativeB Kasper, C Baumgarten, S Bonvalot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2010
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group studyJ R Kroep, M Ouali, H Gelderblom, et al.
British Journal of Cancer|June 24, 2010
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experienceP Ströbel, R Bargou, A Wolff, et al.
British Journal of Cancer|June 18, 2014
Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasisA Schmaus, S Klusmeier, M Rothley, et al.
British Journal of Cancer|July 19, 2012
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG studyS Sleijfer, T Gorlia, C Lamers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)B Kasper, C Baumgarten, J Garcia, et al.
Annals of Surgery|April 4, 1998
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trialB Rau, P Wust, P Hohenberger, et al.
British Journal of Cancer|April 21, 2011
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) studyN Penel, M V Glabbeke, S Mathoulin-Pelissier, et al.
ESMO Open|July 16, 2021
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)M Eriksson, P Reichardt, H Joensuu, et al.
Pageof 16